ViiV gets FDA nod for Rukobia drug for older HIV patients

The FDA has approved Rukobia, a first-in-class drug from ViiV Healthcare intended for older people with HIV, who have been on antiretroviral therapy (ART) for so long it is sta

US advisors add steroids to COVID-19 drug recommendations

The Infectious Diseases Society of America (IDSA) says generic steroids should be used to treat patients hospitalised with COVID-19.

Ferring’s gut microbiome drug clears phase 3 trial in C. dif...

Ferring Pharma has reported what it says is the first positive phase 3 trial of a microbiome therapy – based on healthy bacteria – showing it can reduce recurrences of a seriou

Smartphone UTI test available at home during COVID-19 lockdo...

Regeneron’s Ebola drug heading for October verdict from FDA

Gilead slides as second Chinese trial of remdesivir is stopp...